Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0658
D

Failure to Clarify and Prevent Administration of Contraindicated Medications

Grass Valley, California Survey Completed on 12-08-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to follow its own policy and procedures and did not ensure professional standards of practice were met when a resident with a diagnosis of nontraumatic intracerebral hemorrhage (ICH), hemiplegia, transient ischemic attack, and cerebral infarction was administered medications with known severe drug interactions. Specifically, the resident was given both Heparin and Aspirin, which triggered a drug interaction warning in the medication system due to the risk of enhanced anticoagulant effects. The medication administration record confirmed that both medications were administered on the same day, despite the presence of a severe interaction warning. Interviews with licensed nurses and the Director of Nursing revealed that staff were aware of the resident's diagnosis and the drug interaction warning but did not clarify the orders with the physician as required by facility policy. The pharmacist confirmed that the combination of Aspirin and Heparin is contraindicated in such cases and should have been clarified with the provider. The facility's policy states that any medication order believed to be inappropriate or associated with potential adverse consequences must be discussed with the attending physician or medical director, which was not done in this instance.

An unhandled error has occurred. Reload 🗙